[Cross-border M&As & Investments]

• Represents SK Ecoplant in an acquisition of a global energy platform company

• Represented Samsung C&T in a minority investment and a business collaboration with a leading listed Malaysian construction company

• Represented SK Nexilis and SK Nexilis Malaysia in (i) issuing RCPS for foreign investors and (ii) stamp duty exemption

• Represented SK Holdings in a strategic investment to acquire a minority stake in a U.S. startup

• Represented Netmarble in an acquisition of a global social casino game company, SpinX

• Represented JTBC Studios in a pre-IPO investment from a private equity fund

• Represented JTBC Studios in an acquisition of U.S. production company, Wiip

• Represented Dongwon Industries in a strategic investment to acquire a minority stake in Salmon Evolution

• Represented Hotel Shilla in entering into a strategic partnership with DFASS Group, a leading duty free travel retailer, by acquiring a 44% stake in 3Sixty Duty Free

• Represented Lotte Shopping in its attempt to acquire eBay Korea

• Represented Samyang Holdings in its attempt to acquire a global chemical corporation

• Represented IYUNO Media Group, a Singapore based media localization company, in its acquisition of SDI Media

[Capital Market]

• Represented LG Energy Solution, Kakao Pay, Krafton, Market Kurly, K-Car in Initial Public Offerings on Korea Exchange

[U.S. Patent Litigation & Arbitration]

• Represented Samsung Electronics in a complex action against NuCurrent Inc., which involves trade secrets misappropriation, breach of contract and patent infringement

• Represented Samsung Electronics in a complex action against Elm 3Ds Innovations, which involves trade secrets misappropriation, breach of contract and patent infringement

• Represented Lotte Chemical in an arbitration relating to a Joint Venture petrochemical project in U.S.

• Represented Kolon Industries in an arbitration relating to a petrochemical joint venture in U.S.

[Internal Investigation]

• Represented multiple global pharmaceutical companies (Johnson & Johnson, Astellas Pharma, MicroVention) in anti-corruption internal investigations in Korea